Last reviewed · How we verify

NCT05548192

SmartPICC-1 Feasibility Study Technical Feasibility Study

Completed Last updated 3 March 2023
What this trial tests

trial testing SmartPICC-1 System in Catheter Complications in 42 participants. Completed in 23 August 2022.

Timeline
1 April 2021
Primary endpoint
23 August 2022
23 August 2022

Quick facts

Lead sponsorPiccolo Medical
StatusCompleted
Study typeOBSERVATIONAL
Enrollment42
Start date1 April 2021
Primary completion23 August 2022
Estimated completion23 August 2022
Sites2 locations across United States

Drugs / interventions tested

Conditions studied

Sponsor

Piccolo Medical

Who can join

Adults 22 to 85, any sex, with Catheter Complications. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of this study is to evaluate the safety and technical feasibility of the Piccolo Medical SmartPICC System, indicated for guidance and positioning of commercially available central venous catheters, for PICC placement in adults.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Catheter Complications

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05548192.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing